{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:20:10Z","timestamp":1790104810710,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.dld.2023.11.023","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T12:36:57Z","timestamp":1702298217000},"page":"932-940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Apelin and the gut microbiome: Potential interaction in human MASLD"],"prefix":"10.1016","volume":"56","author":[{"given":"Maria","family":"Effenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Grander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0846-1202","authenticated-orcid":false,"given":"Bela","family":"Hausmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Enrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Pjevac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1794-422X","authenticated-orcid":false,"given":"Heinz","family":"Zoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dld.2023.11.023_bib0001","doi-asserted-by":"crossref","first-page":"92","DOI":"10.23736\/S0391-1977.16.02563-3","article-title":"Adipose tissue, obesity and non-alcoholic fatty liver disease","volume":"42","author":"Polyzos","year":"2017","journal-title":"Minerva Endocrinol"},{"issue":"2","key":"10.1016\/j.dld.2023.11.023_bib0002","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJMe1514957","article-title":"The obesity epidemic\u2013understanding the disease and the treatment","volume":"374","author":"Apovian","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.dld.2023.11.023_bib0003","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"issue":"4","key":"10.1016\/j.dld.2023.11.023_bib0004","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from Global Burden of Disease 2009-2019","volume":"75","author":"Golabi","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2023.11.023_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.dld.2023.11.023_bib0006","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1016\/j.numecd.2021.08.037","article-title":"Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic\/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study","volume":"31","author":"Targher","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.dld.2023.11.023_bib0007","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/apt.12046","article-title":"Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?","volume":"36","author":"Yilmaz","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"10290","key":"10.1016\/j.dld.2023.11.023_bib0008","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.dld.2023.11.023_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081649","article-title":"Adipokines and non-alcoholic fatty liver disease: multiple interactions","volume":"18","author":"Adolph","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.dld.2023.11.023_bib0010","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dld.2023.11.023_bib0011","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","article-title":"Canbay A. Hepatokines and adipokines in NASH-related hepatocellular carcinoma","volume":"74","author":"Kucukoglu","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.dld.2023.11.023_bib0012","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1096\/fj.05-5243fje","article-title":"TNFalpha up-regulates apelin expression in human and mouse adipose tissue","volume":"20","author":"Daviaud","year":"2006","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.dld.2023.11.023_bib0013","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a newly identified adipokine up-regulated by insulin and obesity","volume":"146","author":"Boucher","year":"2005","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.dld.2023.11.023_bib0014","doi-asserted-by":"crossref","first-page":"809","DOI":"10.14740\/jocmr3103w","article-title":"The apelin receptor APJ in hematopoietic stem cells\/progenitor cells in the early stage of non-alcoholic steatohepatitis","volume":"9","author":"Ando","year":"2017","journal-title":"J Clin Med Res"},{"issue":"10","key":"10.1016\/j.dld.2023.11.023_bib0015","first-page":"5313","article-title":"The apelin-APJ system induces tumor arteriogenesis in hepatocellular carcinoma","volume":"34","author":"Muto","year":"2014","journal-title":"Anticancer Res"},{"issue":"18","key":"10.1016\/j.dld.2023.11.023_bib0016","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.7150\/thno.34713","article-title":"APLN promotes hepatocellular carcinoma through activating PI3K\/Akt pathway and is a druggable target","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"1\u20132","key":"10.1016\/j.dld.2023.11.023_bib0017","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11010-019-03581-0","article-title":"Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells","volume":"460","author":"Wang","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.dld.2023.11.023_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.578966","article-title":"Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases","volume":"11","author":"Recinella","year":"2020","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.dld.2023.11.023_bib0019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10.1016\/j.dld.2023.11.023_bib0020","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.dld.2023.11.023_bib0021","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2023.11.023_bib0022","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.dld.2023.11.023_bib0023","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.dld.2023.11.023_bib0024","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/oby.22175","article-title":"Gut microbes and health: a focus on the mechanisms linking microbes, obesity, and related disorders","volume":"26","author":"Rastelli","year":"2018","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.dld.2023.11.023_bib0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2017.05.008","article-title":"Understanding the holobiont: how microbial metabolites affect human health and shape the immune system","volume":"26","author":"Postler","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.dld.2023.11.023_bib0026","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fmicb.2011.00149","article-title":"Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue","volume":"2","author":"Geurts","year":"2011","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.dld.2023.11.023_bib0027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3920\/BM2012.0065","article-title":"Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics","volume":"5","author":"Geurts","year":"2014","journal-title":"Benef Microbes"},{"issue":"12","key":"10.1016\/j.dld.2023.11.023_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11122236","article-title":"Assessing liver fibrosis using the FIB4 index in the community setting","volume":"11","author":"Blanco-Grau","year":"2021","journal-title":"Diagnostics"},{"issue":"9","key":"10.1016\/j.dld.2023.11.023_bib0029","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/hepr.12647","article-title":"Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study","volume":"46","author":"Sun","year":"2016","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.dld.2023.11.023_bib0030","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2023.11.023_bib0031","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2023.11.023_bib0032","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"Ann Hepatol"},{"issue":"12","key":"10.1016\/j.dld.2023.11.023_bib0033","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"issue":"5","key":"10.1016\/j.dld.2023.11.023_bib0034","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/flgastro-2021-102064","article-title":"EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis","volume":"13","author":"Archer","year":"2022","journal-title":"Frontline Gastroenterol"},{"issue":"2","key":"10.1016\/j.dld.2023.11.023_bib0035","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2023.11.023_bib0036","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2023.11.023_bib0037","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiol.2017170554","article-title":"Evidence supporting LI-RADS major features for CT- and MR imaging-based diagnosis of hepatocellular carcinoma: a systematic review","volume":"286","author":"Tang","year":"2018","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.dld.2023.11.023_bib0038","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.dld.2023.11.023_bib0039","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/1462-2920.13023","article-title":"Every base matters: assessing small subunit rRNA primers for marine microbiomes with mock communities, time series and global field samples","volume":"18","author":"Parada","year":"2016","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.dld.2023.11.023_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.669776","article-title":"An economical and flexible dual barcoding, two-step PCR approach for highly multiplexed amplicon sequencing","volume":"12","author":"Pjevac","year":"2021","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.dld.2023.11.023_bib0041","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: high-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"issue":"14","key":"10.1016\/j.dld.2023.11.023_bib0042","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/bioinformatics\/bts252","article-title":"SINA: accurate high-throughput multiple sequence alignment of ribosomal RNA genes","volume":"28","author":"Pruesse","year":"2012","journal-title":"Bioinformatics"},{"issue":"Database issue","key":"10.1016\/j.dld.2023.11.023_bib0043","first-page":"D590","article-title":"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.dld.2023.11.023_bib0044","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12876-023-02721-7","article-title":"Transmission of oral microbiota to the biliary tract during endoscopic retrograde cholangiography","volume":"23","author":"Effenberger","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.dld.2023.11.023_bib0045","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000182","article-title":"A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma","volume":"7","author":"Effenberger","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2023.11.023_bib0046","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.12688\/f1000research.26669.1","article-title":"TreeSummarizedExperiment: a S4 class for data with hierarchical structure","volume":"9","author":"Huang","year":"2020","journal-title":"F1000Res"},{"issue":"12","key":"10.1016\/j.dld.2023.11.023_bib0047","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"6","key":"10.1016\/j.dld.2023.11.023_bib0048","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.21873\/anticanres.13435","article-title":"Prognostic role of apelin receptor expression in hepatocellular carcinoma treated with curative surgical resection","volume":"39","author":"Lee","year":"2019","journal-title":"Anticancer Res"},{"issue":"7516","key":"10.1016\/j.dld.2023.11.023_bib0049","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.dld.2023.11.023_bib0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dld.2023.11.023_bib0051","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cmet.2019.08.002","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"30","author":"Loomba","year":"2019","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.dld.2023.11.023_bib0052","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2019.04.020","article-title":"New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD","volume":"71","author":"Boursier","year":"2019","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2023.11.023_bib0053","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.dld.2023.11.023_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012489","article-title":"Accuracy of FIB-4 to detect elevated liver stiffness measurements in patients with non-alcoholic fatty liver disease: a cross-sectional study in referral centers","volume":"23","author":"Vigan\u00f2","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.dld.2023.11.023_bib0055","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"M\u00f3zes","year":"2022","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.dld.2023.11.023_bib0056","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2468-1253(23)00141-3","article-title":"Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis","volume":"8","author":"M\u00f3zes","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823010411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865823010411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T06:10:45Z","timestamp":1716617445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865823010411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1590865823010411"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2023.11.023","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apelin and the gut microbiome: Potential interaction in human MASLD","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2023.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}